Table 3 Summary of literature report on pneumothorax in COVID-19 patients. Data are presented to compare clinical and radiographic characteristics and clinical outcomes
From: Pneumothorax in COVID-19 disease- incidence and clinical characteristics
| Age yr/Gender | CT characteristics | Complication | Risk Factors | Time to onset, days | Chest tube | Time to resolution (days) | Outcomes | |
|---|---|---|---|---|---|---|---|---|
| Zhou et al. [3] | 38/M | Bilateral GGOs and consolidations in the lower lobes | Pneumomediastinum | None | 11 | 14 | Survived | |
| Wang et al. [5] | 36/F | Bilateral Patchy GGOs and consolidations | Pneumomediastinum | NIV | Day 0–12 days after onset of symptoms | Died due to ARDS | ||
| Sun et al. [6] | 38/M |
Patchy peripheral GGOs. Progression to consolidations and bullae | Mediastinal Emphysema, Giant Bulla, Pneumothorax | NIV |
Pneumomediastinum 7 days Bullae 21 days PNX 30 days | None | ||
| Aiolfi et al. [4] |
56/M 70/M | Bilateral peripheral GGOs | Pneumothorax |
Invasive Mechanical Ventilation Preexisting emphysema | 2 and 5 days after intubation | Yes | Thoracotomy and bleb resection were performed for persistent pneumothorax | |
| Liu et al. [11] | 38/M | Bilateral Patchy GGOs and consolidations, progression to cystic formation | Pneumothorax | None | 26 | None | 5 | Survived |
|
Wang et al. Wang et al. [10] | 62/M | Bilateral areas of GGOs in the peripheral areas |
Pneumomediastinum Pneumothorax Subcutaneous emphysema | None | 20 | None | 16 | Survived |